500 Patriot Way
Hypnion, Inc. is a recently founded, privately-held, biotechnology discovery company whose objective is to become the worldwide leader in sleep/wake neurobiology with the ultimate goal of understanding and being able to treat a wide range of sleep-wake disorders (e.g., insomnia, sleep apnea, excessive sleepiness, sleep-related dystonias) and circadian rhythm abnormalities (e.g., jet-lag, shift-work disorders, delayed or advanced sleep phase syndrome). The technology platform assembled for this includes the creation and molecular analysis of mouse models, genetic and genomic based target discovery, a high-throughput in vivo sleep-wake & physiological assay system, and the ability to quickly and efficiently screen pre-clinical compounds for sleep-wake effects or side effects. Additionally, this platform can be applied in many additional areas of CNS for corporate alliances.
Dale M. Edgar, Ph.D.
Karen Moore, Ph.D.
James F. White, Ph.D.
Chief Operating Officer and Executive Vice President of Research & Development
John F. Dee
President and Chief Executive Officer
Last Updated: 11-01-04